Antiinflammatory effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on zymosan-induced arthritis in mice

Inflammation Research

Volumn 55, Issue 11, 2006, Pages 457-464

  Penido, C ^a   Conte, F P ^a   Chagas, M S S ^a   Rodrigues, C A B ^a   Pereira, J F G ^a   Henriques, M G M O ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Arthritis; Carapa guianensis; Chemokines; Cytokines; Leukocyte trafficking; Oedema

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CARAPA GUIANENSIS; CELL DAMAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; KNEE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PLANT; PLEURA CAVITY; PLEURISY; SYNOVIUM; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; KNEE JOINT; LIMONINS; MACROPHAGES, PERITONEAL; MALE; MELIACEAE; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHYTOTHERAPY; PLANT PREPARATIONS; SEEDS; SYNAPTOTAGMIN I; SYNOVIAL MEMBRANE; ZYMOSAN;

EID: 34147094348     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-5161-8     Document Type: Article

References (38)

1. Banerji B, Nigam SK. Wood constituents of Meliacea: A review. Fitoterapia 1984; LV (1): 3-36.
2. Pereira JFG, Teixeira, Mazzei JL, Gilbert B. Characterization of the chemical constituents of Carapa guianensis Aublet by HPLC-DAD. Boll Chim Farmaceutico 1999; 138(2): 177.
3. Penido C, Costa KA, Pennaforte, RJ, Costa, MFS, Pereira, JFG, Siani, AC et al. Anti-allergic effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on allergen-induced vascular permeability and hyperalgesia. Inflamm Res 2005; 54: 295-303.
4. Penido C, Costa, KA, Costa, MFS, Pereira, JFG, Siani, AC, Henriques, MGMO. Inhibition of allergen-induced eosinophil recruitment by natural tetranortriterpenoids is mediated by the suppression of IL-5, CCL11/eotaxin and NFκB activation. Int. Immunopharmacol 2006; 6: 109-21.
5. Hammer MLA, Johns EA. Tapping an Amazonian plethora: four medicinal plants of Marajó Island, Pará (Brazil). J Ethnopharmacol 1993; 40: 53-75.
6. Lorenzi H, Matos FJ. Plantas Medicinais no Brasil: nativas, exóticas e cultivadas. In: Editora Nova Odessa. Instituto Plantarum de Estudos da Flora, 2002: 332-4.
7. Frasnelli ME, Tarussio D, Chobaz-Péclat V, Busso N, So A. TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Res Ther 2005; 7: 370-9.
8. Pettipher ER, Salter ED. Resident joint tissues, rather than infiltrating neutrophils and monocytes, are the predominant sources of TNF-alpha in zymosan-induced arthritis. Cytokine 1996; 8: 130-3.
9. Vicente AM, Guillen MI, Habib A, Alcaraz MJ. Beneficial effects of heme oxygenase-1 up-regulation in the development of experimental inflammation induced by zymosan. J Pharmacol Exp Ther 2003; 307: 1030-7.
10. Bombini G, Canetti C, Rocha FAC, Cunha FQ. Tumor necrosis factor-α mediates neutrophil migration to the knee synovial cavity during immune inflammation. Eur J Pharmacol 2004; 496: 197-204.
11. Wei X, Leung BP, Arthur HM, McInnes IB, Liew FY. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol 2001; 166: 517-21.
12. van de Loo FA, Arntz OJ, van Enckevort FH, van Lent PL, van den Berg WB. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1 -treated wild-type mice with unabated joint inflammation. Arthritis Rheum 1998; 41: 634-46.
13. Williams RO, Feldmann M, Maini R. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci 1992; 89: 9784-8.
14. Kuwabara K, Yasui K, Jyoyama H, Maruyama T, Fleish JH, Hori Y. Effects of the second-generation leukotriene B(4) receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced artritis in mice. Eur J Pharmacol 2000; 402: 275-85.
15. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 1983; 16: 109.
16. Rosengren S, Firestein GS, Boyle DL. Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2003; 10: 1002-10.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall, RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
18. Dignam J, Lebovitz R, Roeder R. Accurate transcription initiation by RNApolymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res. 1983; 5: 1475-89.
19. Keystone EC, Schorlemmer HU, Pope C, Allison AC. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum 1977; 20: 1396-401.
20. Gegout P, Gillet P, Terlain B, Netter P. Zymosan-induced arthritis in rats. II. Effects of anti-inflammatory drugs. Life Sci 1995; 56: 389-94.
21. Nakagawa T, Akagi M, Hoshikawa H, Chen M, Yasuda T, Mukai S et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis. Arthritis Rheum 2002; 46: 2486-94.
22. Sharma JN, Buchanan WW. Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Toxicol Pathol 1994; 46: 421-33.
23. Rocha FAC, Aragão Jr AGM, Oliveira RC, Pompeu MML, Vale MR, Ribeiro RA. Periarthritis promotes gait disturbance in zymosan-induced arthritis in rats. Inflamm Res 1999; 48: 485-90.
24. De Sanctis GT, MacLean JA, Qin S, Wolyniec WW, Grasemann H, Yandava CN et al. Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation. J Clin Invest 1999; 103: 507-15.
25. Kraan MC, Patel DD, Haringman JJ, Smith MD, Weedon H, Ahern, MJ et al. The development of cinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin 8). Arthritis Res 2001; 3: 65-71.
26. López-Armada MJ, Sánchez-Pernaute O, Largo R, Diez-Ortego I, Palacios I, Egido J et al. Modulation of cell recruitment by antiinflammatory agents in antigen-induced arthritis. Ann Rheum Dis 2002; 61: 1027-30.
27. van den Berg WB. Arguments for interleukin 1 as a target in chronic arthritis. Ann Rheum Dis 2000; 59: 81-4.
28. Bakker A, Joosten LAB, Arntz OJ, Helsen MMA, Bendele AM, van de Loo FAJ et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997; 40: 893-900.
29. van de Loo FAJ, Arntz OJ, Otterness IG, van den Berg WB. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 1992; 19: 348-56.
30. van den Berg WB, Joosten LAB, Helsen MMA, van de Loo AAJ. Amelioration of established murine collagen induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 1994; 95: 237-43.
31. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005; 174: 5016-23.
32. Matsumoto N, Ariga A, To-e S, Nakamura H, Agata N, Hirano S et al. Synthesis of NF-κB Activation Inhibitors Derived from Epoxyquinomicin C. Bioorg Med Chem Lett 2000; 10: 865-9.
33. Umezawa K, Ariga A, Matsumoto N. Naturally occurring and synthetic inhibitors of NF-kappaB functions. Anticancer Drug Des 2000; 15: 239-44.
34. Aikawa Y, Yamamoto M, Yamamoto T, Morimoto K, Tanaka K. An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS-and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation. Inflamm Res 2002; 51(4): 188-94.
35. Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients. Common transcriptional regulatory mechanism between interleukin-8 and interleukin-1β. Arthritis Rheum 2004; 50: 1437-47.
36. Friedland JS, Constantin D, Shaw TC, Stylianou E. Regulation of interleukin-8 gene expression after phagocytosis of zymosan by human monocytic cells. J Leukoc Biol 2001; 70: 447-54.
37. Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS et al. NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005; 174: 5781-8.
38. Cheon H, Yu SJ, Yoo DH, Chae IJ, Song GG, Sohn J. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-β1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol 2002; 127: 547-52.